Core technology

                                                             Therapy area

The small molecule compound targeting helicase protein was developed by KeYe Life it has a brand new structure. The compound showed good inhibitory activity against target proteins both in vivo and in vitro, and had no significant inhibitory effect on other proteins of the same family. In terms of indications of the product, it includes the treatment of a variety of solid tumors such as colon cancer, lung cancer, pancreatic cancer, liver cancer and lymphoma.